GENB

9.5408.00%
MT

Michael T. Nally

CEO & Director

Mr. Michael T. Nally, also known as Mike, M.B.A, serves as the Chief Executive Officer and Director at Generate Biomedicines, Inc. since March 31, 2021. He was President of Generate Biomedicines, Inc from March 2021 to January 2026. He joined Generate Biomedicines in 2021. He serves as Director at Harbinger Health, Inc. He serves as a CEO-Partner at Flagship Pioneering Inc since March 2021. He joined Flagship Pioneering in 2021. In this role, he has considerable expertise in biopharma to help achieve the highest possible value creation for Flagship and its companies. Mr. Nally serves as Independent Director of PPG Industries, Incorporated and has served as its Director since February 18, 2021. Previously, Mr. Nally was Executive Vice President and Chief Marketing Officer of Merck & Co., Inc. from January 2019 to March 31, 2021. Mr. Nally co-leads Merck's human health business and is responsible for developing Merck strategy and commercialization model. From September 2016 to January 2019, Mr. Nally served as President, Global Vaccines and delivered significant business growth and a dramatic increase in the reach and public health impact of pediatric, adolescent and adult vaccines. Mr. Nally has been at Merck since 2003 and served in a number of roles with responsibilities including being the Managing Director of UK, Ireland from January 2014 to August 2016 and Sweden as well a variety of roles in Commercial Operations, Business Development and Investor Relations. Previously, Mr. Nally served in key management positions in strategic initiatives, commercial operations, business development and investor relations at Merck. He also previously served as director of Hilleman Laboratories. He holds a Master of Business Administration degree from Harvard Business School, a degree in accounting and finance from the London School of Economics and a Bachelor of Arts degree in economics from Middlebury College.

Positions